Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
- 22 April 1977
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 196 (4288) , 441-444
- https://doi.org/10.1126/science.191908
Abstract
A hypothetical model of the active site of angiotensin-converting enzyme, based on known chemical and kinetic properties of the enzyme, has enabled us to design a new class of potent and specific inhibitors. These compounds, carboxyalkanoyl and mercaptoalkanoyl derivatives of proline, inhibit the contractile response of guinea pig ileal strip to angiotensin I and augment its response to bradykinin. When administered orally to rats, these agents inhibit the pressor effect of angiotensin I, augment the vasodepressor effect of bradykinin, and lower blood pressure in a model of renovascular hypertension.This publication has 17 references indexed in Scilit:
- Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lungPublished by Elsevier ,2002
- Reciprocation of Renin Dependency with Sodium Volume Dependency in Renal HypertensionScience, 1975
- Angiotensin I converting enzyme.Circulation Research, 1975
- Reversible Inhibition of Carboxypeptidase A. II. Inhibition of Esterase Activity by Dicarboxylic Acid AnionsCanadian Journal of Chemistry, 1974
- Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venomCellular and Molecular Life Sciences, 1973
- Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animalsEuropean Journal of Pharmacology, 1973
- Binding of the by-product analog benzylsuccinic acid by carboxypeptidase ABiochemistry, 1973
- A technique for prolonged, continuous recording of blood pressure of unrestrained ratsCardiovascular Research, 1972
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971
- Carboxycathepsin—a key regulatory component of two physiological systems involved in regulation of blood pressureClinica Chimica Acta; International Journal of Clinical Chemistry, 1971